Optimal management of hereditary hemorrhagic telangiectasia. - Wikidata - awgldk - TriplyDB

Optimal management of hereditary hemorrhagic telangiectasia.

Optimal management of hereditary hemorrhagic telangiectasia.

http://www.wikidata.org/entity/Q34388065

about

Mononuclear cells and vascular repair in HHT Hereditary hemorrhagic telangiectasia and pregnancy: potential adverse events and pregnancy outcomes Clarification of mural cell coverage of vascular endothelial cells by live imaging of zebrafish.Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.Diagnosis and treatment of hereditary hemorrhagic telangiectasia in a pediatric patient with chronic cyanosis.Intra-venous bevacizumab in hereditary hemorrhagic telangiectasia (HHT): A retrospective study of 46 patients.The clinical characteristics and long-term prognosis of pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia.Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective

P2860

Q28084374-FA2A66D6-EACE-48E8-B765-02BFD7E03E74 Q33758460-3FD1B06F-EF4A-4A36-A231-1533AB0CCCDB Q36856102-081BF64A-0E6D-4453-B3B3-0CFB91066777 Q42279034-E31F2D35-FAB2-4921-A86E-213AF475BC8F Q42327788-028B8490-FEE9-4584-A4D5-29305EF0F21B Q47346411-B439E872-D112-4FDF-A147-2E05CDBA016B Q53706550-D4941BEF-9FA9-4240-9007-55E01C2161E4 Q57163936-A9BFFFC4-AC78-471B-819C-D5A4FEBAF2A5

P2860

Optimal management of hereditary hemorrhagic telangiectasia.

http://www.wikidata.org/entity/Q34388065

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Optimal management of hereditary hemorrhagic telangiectasia.

@ast

Optimal management of hereditary hemorrhagic telangiectasia.

@en

Optimal management of hereditary hemorrhagic telangiectasia.

@nl

type

label

Optimal management of hereditary hemorrhagic telangiectasia.

@ast

Optimal management of hereditary hemorrhagic telangiectasia.

@en

Optimal management of hereditary hemorrhagic telangiectasia.

@nl

prefLabel

Optimal management of hereditary hemorrhagic telangiectasia.

@ast

Optimal management of hereditary hemorrhagic telangiectasia.

@en

Optimal management of hereditary hemorrhagic telangiectasia.

@nl

P1433

Q34388065-D0B495A4-9A78-4B5C-B8FB-CBF9E61E357C

P1476

Q34388065-000ADBBA-39AC-4BFA-A24E-596825577B0F

P2093

Q34388065-3560C8A0-39EB-4357-814C-FAA72D696684

Q34388065-BA6AEE4E-29A4-4F2E-96FA-FE347DC6E8B1

Q34388065-CE813A61-94BB-491E-B877-1A706D7BE134

Q34388065-E013E4D6-7F09-42DD-B9D0-F2D4FD266A74

P2860

Q34388065-0080CE71-EAE9-4B90-964F-E53EA0483872

Q34388065-009FE4F4-3CA2-44E2-AC9B-8E05012F9F3D

Q34388065-00B8E8CB-A67F-4DFE-9675-6BE04FCDAD8B

Q34388065-00EFBB01-9722-4720-9BE5-29C6985B164C

Q34388065-01A3CE51-58B7-44A3-B743-3A1FEB743552

Q34388065-01B03040-F9D8-4CA5-8BA1-2853565BD0A4

Q34388065-030C57AC-2D70-4B6E-8B14-B1A31A6EA5FA

Q34388065-03132D6A-4166-4CC8-AD30-3CE9833ED016

Q34388065-03BF13CB-7BF4-4F3F-BCA9-E1C3734FCCFD

Q34388065-0858E83F-9DC6-4BEB-921C-BDE85E661D52

P304

Q34388065-87EA2359-981B-45B7-A9C5-3A9FF1E43BD4

P31

Q34388065-552E2DFC-9BB1-46D9-9CA3-5A63852D68E5

P356

Q34388065-CF4E137F-E1CE-485A-BD62-28F07924B216

P478

Q34388065-A7C9ADE5-D5CA-42A8-9462-F8CBEB1DCB28

P577

Q34388065-5074A80B-939F-441C-B343-274644107BDA

P698

Q34388065-1DEA65D4-C07C-402C-B777-3DAEE86C2002

P921

Q34388065-778A1CB4-B7DF-46DA-A2B8-D4F74CEE25DB

P932

Q34388065-1504C6A3-822C-49FF-A2A8-9CA8AA2D875D

P356

P1433

Journal of Blood Medicine

P1476

Optimal management of hereditary hemorrhagic telangiectasia.

@en

P2093

Arjun Gupta

http://www.w3.org/2001/XMLSchema#string

Monica Khunger

http://www.w3.org/2001/XMLSchema#string

Neetika Garg

http://www.w3.org/2001/XMLSchema#string

Nilay Kumar

http://www.w3.org/2001/XMLSchema#string

P2860

Embolisation for pulmonary arteriovenous malformation

BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia

Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

VEGF inhibition and renal thrombotic microangiopathy

A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5

Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia

Regression of cutaneous and gastrointestinal telangiectasia with sirolimus and aspirin in a patient with hereditary hemorrhagic telangiectasia

Radiation dose to the brain and subsequent risk of developing brain tumors in pediatric patients undergoing interventional neuroradiology procedures.

The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.

P304

191-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JBM.S45295

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25342923

http://www.w3.org/2001/XMLSchema#string

P921

hereditary hemorrhagic telangiectasia

P932

4206399

http://www.w3.org/2001/XMLSchema#string